These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6367794)

  • 21. An open comparison between free and a fixed combination of diuretic and beta-blocker in the management of essential hypertension.
    Forrest WA
    J Int Med Res; 1980; 8(2):127-31. PubMed ID: 6102939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxprenolol plus cyclopenthiazide-KCl versus methyldopa in the treatment of hypertension.
    Seedat YK
    S Afr Med J; 1979 Jan; 55(4):114. PubMed ID: 424946
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of slow oxprenolol and a combination of slow oxprenolol and cyclopenthiazide on plasma lipoproteins.
    Ballantyne D; Ballantyne FC; McMurdo
    Atherosclerosis; 1981 Jun; 39(3):301-6. PubMed ID: 7259814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled clinical study on antihypertensive treatment with a diuretic and methyldopa compared with a beta-blocking agent and hydralazine.
    Hansen M; Hansen OP; Lindholm J
    Acta Med Scand; 1977; 202(5):385-8. PubMed ID: 335794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the antihypertensive effects of indapamide and cyclopenthiazide.
    James I; Griffith D; Davis J; Wollard M; Waddell G
    Postgrad Med J; 1981; 57 Suppl 2():39-41. PubMed ID: 7322959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Slow-Trasicor (sustained-release oxprenolol hydrochloride 160 mg) in the treatment of essential hypertension: a multicentre evaluation of 4,400 patients.
    Forrest WA
    Br J Clin Pract; 1977 Nov; 31(11):181-6. PubMed ID: 339937
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparative study of frusemide-amiloride and cyclopenthiazide-potassium chloride in the treatment of congestive cardiac failure in general practice.
    Crawford RJ; Allman S; Gibson W; Kitchen S; Richards HH
    J Int Med Res; 1988; 16(2):143-9. PubMed ID: 3378660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prazosin alone and combined with a thiazide diuretic in the treatment of hypertension.
    Seedat YK; Seedat MA; Bhoola R
    S Afr Med J; 1977 Apr; 51(14):461-3. PubMed ID: 860171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xipamide and cyclopenthiazide in essential hypertension--comparative effects on blood pressure and plasma potassium.
    MacGregor GA; Banks RA; Markandu ND; Roulston J
    Br J Clin Pharmacol; 1982 Jun; 13(6):859-63. PubMed ID: 7046777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low and conventional dose cyclopenthiazide on glucose and lipid metabolism in mild hypertension.
    McVeigh GE; Dulie EB; Ravenscroft A; Galloway DB; Johnston GD
    Br J Clin Pharmacol; 1989 Apr; 27(4):523-6. PubMed ID: 2655692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxprenolol plus cyclopenthiazide-kci versus methyldopa in the treatment of hypertension.
    Levenstein JH
    S Afr Med J; 1979 Apr; 55(17):656. PubMed ID: 462285
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hypotensive effect of delayed-action oxprenolol and chlorthalidone in combined form in patients with primary arterial hypertension].
    Cybulska I; Sznajderman M
    Pol Tyg Lek; 1984 Apr; 39(15):501-3. PubMed ID: 6384962
    [No Abstract]   [Full Text] [Related]  

  • 33. Proceedings: Clinical studies: beta-blockade in systemic hypertension.
    Goldberg AD; Raftery EB
    Scott Med J; 1974 Jan; 19(1):44-5. PubMed ID: 4594823
    [No Abstract]   [Full Text] [Related]  

  • 34. Oral diuretics and hypertension.
    Waal-Manning HJ
    N Z Med J; 1982 Apr; 95(706):287-8. PubMed ID: 6953383
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of the effects of the slow release formulations of metoprolol and oxprenolol in hypertension.
    Comerford MB; Besterman EM
    Ann Clin Res; 1982 Feb; 14(1):27-31. PubMed ID: 7137874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide.
    McVeigh G; Galloway D; Johnston D
    BMJ; 1988 Jul; 297(6641):95-8. PubMed ID: 3044503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W; Wilson T
    Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative clinical trial of bemetizide/triamterene and cyclopenthiazide/potassium chloride combinations in patients with mild to moderate hypertension.
    Wray R; Benton KG; Whitehill D; Wright B; Weener W; Whittington JR
    Curr Med Res Opin; 1983; 8(9):665-74. PubMed ID: 6365467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One year follow-up of hyperuricaemic hypertensive patients treated with tienilic acid or a diuretic with or without uric acid-lowering drugs.
    Waal-Manning HJ; Simpson FO
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():379s-382s. PubMed ID: 396085
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of refractory hypertension with a fixed oxprenolol/chlorthalidone/hydralazine combination. Results of an open multicenter trial].
    Krönig B; Wendt G
    Med Welt; 1983 Sep; 34(35):941-4. PubMed ID: 6355745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.